Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP635547.RASLBmPpbOt26ZOF8Hy_iogWZpG0Dt2Aq6Oum477WNsc4130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635547.RASLBmPpbOt26ZOF8Hy_iogWZpG0Dt2Aq6Oum477WNsc4130_provenance.
• NP808001.RAuixMw0ykFRRQMbFenmgB2VjiGmXvD1OUOG4Lgz7loRM130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808001.RAuixMw0ykFRRQMbFenmgB2VjiGmXvD1OUOG4Lgz7loRM130_provenance.
• NP423779.RAH8b0VRJsFmtMpCkzy9tQ9KBu8f1JZRLrOG_MG-Zr-Dc130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423779.RAH8b0VRJsFmtMpCkzy9tQ9KBu8f1JZRLrOG_MG-Zr-Dc130_provenance.
• NP440077.RAIJ4tbCTwXiHUdoV5yRVEH-Pg7N8T09QM_F4GSE9l4OU130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440077.RAIJ4tbCTwXiHUdoV5yRVEH-Pg7N8T09QM_F4GSE9l4OU130_provenance.
• NP422442.RAX4eLBDEHI0mdYZk874c_HVNij3ptrmT1eg9MUBYMwEQ130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422442.RAX4eLBDEHI0mdYZk874c_HVNij3ptrmT1eg9MUBYMwEQ130_provenance.
• assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP259143.RAsJsTIs0fJQsepERwJ4WERbsZIXLp0apzm-HwVtG930A130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259143.RAsJsTIs0fJQsepERwJ4WERbsZIXLp0apzm-HwVtG930A130_provenance.
• NP323928.RABi01DMJqqeoacf2BySUJ8Qe03Ds_9yHD0IEHLOAISRw130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323928.RABi01DMJqqeoacf2BySUJ8Qe03Ds_9yHD0IEHLOAISRw130_provenance.
• NP323932.RACg2JacXteRlJixqCK5Fi71yxEaraHtnBNw7pSNdvzn4130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323932.RACg2JacXteRlJixqCK5Fi71yxEaraHtnBNw7pSNdvzn4130_provenance.
• NP323923.RAvgId4QxFIS08SdUB8u5P5ecD0XShsnSkMgF065VBQkM130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323923.RAvgId4QxFIS08SdUB8u5P5ecD0XShsnSkMgF065VBQkM130_provenance.
• NP323927.RAt3yJpwMpvBDavT427eEj6BCiqOeE5kumFTNWITSePSI130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323927.RAt3yJpwMpvBDavT427eEj6BCiqOeE5kumFTNWITSePSI130_provenance.
• NP259134.RA3-uSpUtRq2FeVJ8rTW8h5c5-fvT9BtCa2tcI_1DFq0g130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259134.RA3-uSpUtRq2FeVJ8rTW8h5c5-fvT9BtCa2tcI_1DFq0g130_provenance.
• NP753264.RAFI-N2iMDfdpc3ly5hO0QplMJGmZLq0GOTyD2vNuoPVY130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753264.RAFI-N2iMDfdpc3ly5hO0QplMJGmZLq0GOTyD2vNuoPVY130_provenance.
• NP259138.RAOBziiovZiMonnqamGQkVkYRtRXH8LShQhgzWDOWzp6s130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259138.RAOBziiovZiMonnqamGQkVkYRtRXH8LShQhgzWDOWzp6s130_provenance.
• NP323929.RA-RejBYpndWRDYjBPGsY9l5Y_Sm51orN5QqR9oeT_TIs130_assertion description "[Mutations in the TP53 gene were present in 70% of adrenocortical carcinomas, associated with abnormal P53 and CDN1 expression, but not in benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323929.RA-RejBYpndWRDYjBPGsY9l5Y_Sm51orN5QqR9oeT_TIs130_provenance.